Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Feb 13;14:1116839. doi: 10.3389/fimmu.2023.1116839

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Pei, Zhang, Yang, Kang, Chen, Zhao, Dai, Zheng, Xia and Xie

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Expression analysis and experimental validation of PGK1. (A) Pan-cancer expression profile of PGK1. (B–D) The overall survival (OS), disease-specific survival (DSS), and progression-free survival (PFS) analysis of PGK1 in the TCGA cohort. (E) The Relapse free survival (RFS) analysis of PGK1 in the GSE22219 cohort. (F) PCR assay of clinical samples. PGK1 was highly expressed in BC. (G) PCR assay revealed the expression of PGK1 in different cell lines. PGK1 was highly expressed in four BC cell lines compared to HBL-100 cell lines. (H) PGK1 was knocked down in MCF-7 and MDA-MB-231. (I, J) CCK-8 showed that the proliferation activity of the cells that knockdown PGK1 was dramatically reduced. *P<0.05, **P< 0.01, ***P<0.001.